News & Events

EDH AND TERTHERA ENTERS INTO EXCLUSIVE DISTRIBUTION AGREEMENT FOR TERBIUM-161

Agreement will enable a swift introduction of Tb-161 into Türkiye, Bulgaria and Azerbaijan, enabling the application of a novel radiopharmaceutical for cancer healthcare. BREDA, 17 October 2023 – EDH Nükleer Tıp & Sağlık Hizmetleri (“EDH”), a trailblazer in the domain of radiopharmacy and nuclear medicine,and TerThera BV are pleased to announce the signing of an exclusive distribution agreement for the regions Türkiye, Bulgaria and Azerbaijan. Terbium-161, a carrier free lanthanide produced by neutron activation, is a highly promising radionuclide for

READ MORE

Gen Era and EDH have joined forces

Gen Era Diagnostics and EDH Nuclear Medicine and Healthcare Services have joined forces by bringing together their expertise in personalized diagnosis and treatment.   Gen Era, a leading genomics services company for Next Generation Sequencing (NGS), Molecular Biology, Bioinformatics and

READ MORE